Editorial · 30 Dec 2025
Short communicationPublished 29 Aug 2025
Biosimilars: Cost Savings, Access, and Safe Integration
Faculty of Pharmacy, Charles University, Czech Republic
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biosimilars are biological medicines demonstrating high similarity to reference products with no clinically meaningful differences in safety, purity, or potency. Their development pathways are designed for efficiency, offering cost savings and improved patient access. Keyconsiderationsincludeanalytical similarity, immunogenicity assessment, and pharmacovigilance. Economicbenefitsand regulatory frameworks, emphasizing a totality of evidence approach, drive adoption. Healthcare professional and patient acceptance, supported by real-world data, are crucial. Interchangeability is vital for market penetration, with evolving scientific and regulatory considerations
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Research and Development in Pharmacy & Life Sciences.
Short communication · 30 Dec 2025
Advancements in Life Sciences for Disease Treatment
Editorial · 30 Dec 2025
Enhancing Drug Bioavailability Through Advanced Formulation Design
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Research and Development in Pharmacy & Life Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Dr. Peter Novak”
